Tyler Abarca1, Yubo Gao2, Varun Monga3, Munir R Tanas4, Mohammed M Milhem3, Benjamin J Miller5. 1. Carver College of Medicine, University of Iowa, Iowa City, Iowa. 2. Department of Internal Medicine, University of Iowa, Iowa City, Iowa. 3. Division of Hematology, Oncology, and Blood and Marrow Transplantation, Department of Internal Medicine, University of Iowa, Iowa City, Iowa. 4. Department of Pathology, University of Iowa, Iowa City, Iowa. 5. Department of Orthopaedics and Rehabilitation, University of Iowa, Iowa City, Iowa.
Abstract
BACKGROUND AND OBJECTIVES: The purpose of this investigation was to determine the effect of hospital volume on treatment decisions, treatment results, and overall patient survival in extremity soft tissue sarcoma. METHODS: The National Cancer Database was used to identify patients ≥18 years of age with non-metastatic soft tissue sarcoma of the extremity treated with surgery. Patients in high- and low-volume centers were matched by propensity score and placed into two equal comparative groups of 2437 patients each. RESULTS: Chemotherapy was used at a higher rate in high-volume centers (22% vs 17%, P < 0.001) and external beam radiation usage was similar (55% vs 52%, P = 0.108). There was a lower incidence of positive margins in high-volume centers (12% vs 17%, P < 0.001). There was no significant difference in the rates of limb salvage surgery or readmissions at high-volume hospitals compared to low-volume. In a multivariate Cox proportional hazards model, low-volume facilities demonstrated diminished overall survival at all time points (hazard ratio at 5 years = 1.24, 95%CI 1.10-1.39). CONCLUSIONS: Treatment at high-volume hospitals was associated with fewer positive margins and increased overall survival at 2, 5, and 10 years. Continued efforts should focus on optimizing the balance between patient access to specialty care and experience of the treating center.
BACKGROUND AND OBJECTIVES: The purpose of this investigation was to determine the effect of hospital volume on treatment decisions, treatment results, and overall patient survival in extremity soft tissue sarcoma. METHODS: The National Cancer Database was used to identify patients ≥18 years of age with non-metastatic soft tissue sarcoma of the extremity treated with surgery. Patients in high- and low-volume centers were matched by propensity score and placed into two equal comparative groups of 2437 patients each. RESULTS: Chemotherapy was used at a higher rate in high-volume centers (22% vs 17%, P < 0.001) and external beam radiation usage was similar (55% vs 52%, P = 0.108). There was a lower incidence of positive margins in high-volume centers (12% vs 17%, P < 0.001). There was no significant difference in the rates of limb salvage surgery or readmissions at high-volume hospitals compared to low-volume. In a multivariate Cox proportional hazards model, low-volume facilities demonstrated diminished overall survival at all time points (hazard ratio at 5 years = 1.24, 95%CI 1.10-1.39). CONCLUSIONS: Treatment at high-volume hospitals was associated with fewer positive margins and increased overall survival at 2, 5, and 10 years. Continued efforts should focus on optimizing the balance between patient access to specialty care and experience of the treating center.
Authors: J W Harmon; D G Tang; T A Gordon; H M Bowman; M A Choti; H S Kaufman; J S Bender; M D Duncan; T H Magnuson; K D Lillemoe; J L Cameron Journal: Ann Surg Date: 1999-09 Impact factor: 12.969
Authors: Thijs van Dalen; Adriaan Hennipman; Frits Van Coevorden; Harald J Hoekstra; Bert N van Geel; Piet Slootweg; Cherry F Albus Lutter; Murray F Brennan; Samuel Singer Journal: Ann Surg Oncol Date: 2004-04-12 Impact factor: 5.344
Authors: Xianglin L Du; Shenying Fang; Ann L Coker; Maureen Sanderson; Corrine Aragaki; Janice N Cormier; Yan Xing; Beverly J Gor; Wenyaw Chan Journal: Cancer Date: 2006-03-15 Impact factor: 6.860
Authors: Juan C Gutierrez; Eduardo A Perez; Frederick L Moffat; Alan S Livingstone; Dido Franceschi; Leonidas G Koniaris Journal: Ann Surg Date: 2007-06 Impact factor: 12.969
Authors: Anusha Kalbasi; Mitchell Kamrava; Fang-I Chu; Donatello Telesca; Ritchell Van Dams; Yingli Yang; Dan Ruan; Scott D Nelson; Sarah M Dry; Jackie Hernandez; Bartosz Chmielowski; Arun S Singh; Susan V Bukata; Nicholas M Bernthal; Michael L Steinberg; Joanne B Weidhaas; Fritz C Eilber Journal: Clin Cancer Res Date: 2020-02-13 Impact factor: 12.531
Authors: Brendan L Hagerty; John Aversa; Laurence P Diggs; Dana A Dominguez; Reed I Ayabe; Andrew M Blakely; Jeremy L Davis; Carrie Luu; Jonathan M Hernandez Journal: Surgery Date: 2020-07-20 Impact factor: 3.982
Authors: Emma L Herbach; Bradley D McDowell; Elizabeth A Chrischilles; Benjamin J Miller Journal: Am J Clin Oncol Date: 2022-07-06 Impact factor: 2.787
Authors: Siyer Roohani; Felix Ehret; Marta Kobus; Anne Flörcken; Sven Märdian; Jana Käthe Striefler; Daniel Rau; Robert Öllinger; Armin Jarosch; Volker Budach; David Kaul Journal: Radiat Oncol Date: 2022-09-14 Impact factor: 4.309
Authors: Annika Frei; Mario F Scaglioni; Pietro Giovanoli; Stefan Breitenstein; Philip Heesen; Bruno Fuchs Journal: Cancers (Basel) Date: 2022-03-18 Impact factor: 6.639